Tipolo, Jp L.
HRN: 18-04-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
CEFTRIAXONE 1G (VIAL)
01/31/2024
02/07/2024
IV
2g
OD ( ) ANST
Clavicular Fx
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes